Advance care planning for 600 Chinese patients with end-stage renal disease  by Yuen, Sze-Kit et al.
Hong Kong Journal of Nephrology (2016) 19, 19e27Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.hkjn-onl ine.comORIGINAL ARTICLEAdvance care planning for 600 Chinese
patients with end-stage renal disease
Sze-Kit Yuen*, Hay Ping Suen, Oi-Ling Kwok, Sai-Ping Yong,
Man-Wah TseDepartment of Medicine & Geriatrics, Caritas Medical Centre, Sham Shui Po, Kowloon, Hong Kong
Available online 10 August 2016KEYWORDS
advance care
planning;
dialysis;
palliative care;
renal failure* Corresponding author. Department
Hong Kong.
E-mail address: skityuen@yahoo.co
http://dx.doi.org/10.1016/j.hkjn.201
1561-5413/ª 2016 Hong Kong Society
CC BY-NC-ND license (http://creativAbstract Background/purpose: There is increasing recognition of the need to integrate
advance care planning (ACP) into end-stage renal disease (ESRD) care with attention to med-
ical, ethical, psychosocial, and spiritual issues but publications comparing patients who chose
renal replacement therapy (RRT) and renal palliative care (RPC) is scarce. We here share our
experience on ACP for ESRD patients in a center with renal replacement and palliative pro-
grams in place.
Methods: From June 2006 to December 2011, ESRD patients were empowered to make an
informed choice of future medical care in a structured ACP that was emphasized to be an
ongoing process. Patients who opted for RRT and RPC would be followed up at the predialysis
clinic and the one-stop multidisciplinary RPC clinic, respectively. This was a single-center
study in a secondary care hospital. A total of 600 patients (265 RRT, 335 RPC) were enrolled
and followed up over a median of 782 days.
Results: The majority of patients and relatives declined dialysis because of perceived physical
burden. Only 1.6% of palliative care patients changed their decision and commenced dialysis.
Baseline characteristics differed between patients who chose RRT or RPC. Survival declined ac-
cording to the modified Charlson Comorbidity Index scores. Older age, mental incompetence,
hyperlipidemia, high modified Charlson Comorbidity Index, low estimated glomerular filtration
rate, and low albumin were important independent predictors of poor survival. Factors
affecting the ACP decision were discussed in the Chinese culture context.
Conclusion: A structured ACP could empower the patient to make an informed decision on the
management of ESRD.
背景: 於未期腎病患者的照顧中加入關注身心社靈和倫理問題的預設照顧計劃(ACP)受到日益重
視，但有關比較接受腎替代療法和接受腎臟紓緩治療文獻討論為數不多。作為同時提供腎透析服
務以及腎臟紓緩治療的部門，本文旨在分享我們為未期腎病者討論預計照顧計劃的經驗。
方法: 自二零零六年六月至二零一零五月間，透過有組織的預設照顧計劃討論，未期腎病患者會
被鼓勵就未來的治療計劃作出知情選擇。選擇腎透析和腎臟紓緩治療的病人會分別於透析預備門of Medicine & Geriatrics, Caritas Medical Centre, 111, Wing Hong Street, Sham Shui Po, Kowloon,
m.hk (S.-K. Yuen).
6.04.001
of Nephrology. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the
ecommons.org/licenses/by-nc-nd/4.0/).
20 S.-K. Yuen et al.診和一站式跨科際腎臟紓緩治療門診去覆診。本研究於一家二級醫院進行。總共有六百病人參與
此研究，當中265名接受腎透析，335名接受腎臟紓緩治療，其中位跟進日數為782日。
結果: 大部份病人和家屬之所以拒絕腎透析是由於預計的身體負累，只有百分之一點六接受腎臟
紓緩治療會改變主義而接受腎透析。選擇腎透析和腎臟紓緩治療的病人在基本的身體狀況有明顯
分別。生存率亦隨著修改版查爾森共病量表的分數而下降。年長、精神自主能力缺欠、高血脂、
修改版查爾森共病量表分數高、腎小球濾過率低、白蛋白低均屬重要暨獨立的因素以預計較差的
生存率。本文亦會探討在中國文化處境下影響預設照顧計劃討論的因素。
結論: 有組織的預設照顧計劃討論能幫助病人在未期腎病的醫療方向作出知情的選擇。Introduction
The global prevalence of end-stage renal disease (ESRD) is
increasing. In the USA, older patients comprise the fastest
growing population initiated on renal replacement therapy
(RRT) with the proportion older than 70 years rising from
19.2% in 2000 to 24.9% in 2012. In the UK, up to 25% of
patients commenced on RRT are aged over 75 years.1 Irre-
spective of age, more patients with multiple comorbidities
were commenced on RRT. In the USA and UK, 40% of dia-
lyzed patients had diabetes mellitus (DM).1,2 Despite pro-
longed survival, dialyzed patients suffered impaired quality
of life (QOL) with physical and psychological morbid-
ities.3e5 Older patients had the worst outcomes with
heightened mortality, and poor functional status and QOL.2
Death from withdrawal of dialysis had been increasing,
especially among elderly, and accounted for 25% of RRT
mortality in the USA and 19% in the UK.1,2 In the past
decade, the increasing number of elders being started on
RRT and the increasing dialysis withdrawal rate called upon
the option of no dialysis.6 The latest Renal Physicians As-
sociation practice guideline affirmed patient’s right in
refusing initiation of dialysis in care planning.7 While
recognizing the appropriateness of nondialytic treatment in
some patients, it is prudent to provide them with access to
active palliative care to evade sense of abandonment.8
Life expectancy in Hong Kong is among the longest in the
world. The median age of incident RRT patients rose from
56 years to 60 years, while DM among incident and preva-
lent patients had increased from 26.2% and 20.8% in 1996 to
46% and 33.7% in 2011, respectively.9 Patients not
commenced on dialysis were historically categorized as
receiving conservative management. It was only in recent
years that public palliative care service was funded to serve
patients with ESRD.
To make an informed choice in accordance to their own
values and preferences, patients should be provided with
adequate information and empowered to decide on their
medical care based on weighing of burdens and benefits.7,10
Advance care planning (ACP) is part of the comprehensive
ESRD care with attention to ethical, psychosocial, and
spiritual issues related to starting, continuing, withholding,
and withdrawing dialysis.11 In Hong Kong, the importance of
integrating ACP into the ESRD care had been recognized.12
Nevertheless, the quality of ACP is affected by various
factors. Firstly, ACP is an operator-dependent process and
affected by the facilitator’s communication skills and
rapport with the patient. Secondly, initiating ACP at a
suitable time along the disease trajectory requires carefulconsideration; the patient may be unprepared when too
early or unable to participate in lucid discussion when too
late. Thirdly, unlike completing an advance directive, the
ACP process can be variable and unstructured when clini-
cians are not trained relevantly.
We report our experience in constructing and imple-
menting a structured ACP process for patients with ESRD in
a center with a renal palliative care (RPC) program. With
designated ACP facilitators, early engagement of patients
and families, defined scope of prognostic assessment, in-
formation giving and discussion, as well as standardized
documentation for ongoing care, patients were empowered
to make informed choices.Methods
We recruited all adult (aged  18 years) patients who un-
derwent ACP from June 2006 to Dec 2011. Clinicians
conventionally refer diabeticswith serumcreatinine 350mM
or nondiabetics with serum creatinine 450mM for ACP, but
patients presenting late with overt symptoms and limited life
span were encountered. The first ACP interview mostly took
place in a designated clinic and facilitated by an experienced
nephrologist and a medical social worker (MSW). Supple-
mented by pamphlets, the scope of discussion included de-
livery of information on diagnosis, prognosis, treatment
options and their benefits and burdens. End-of-life issues
were discussed only if there were urgent clinical needs.
Factors affecting prognosis were assessed at baseline. This
included the cause and irreversibility of renal failure, esti-
mated glomerular filtration rate (eGFR), comorbidities and
modified Charlson Comorbidity Index (mCCI),13 biochemical
parameters, and functional and socioeconomic statuses. The
patient’s values andpreferenceswere exploredand caregiver
distress identified. The MSW served to provide on-site
emotional support, facilitate family discussion, provide
timely information on social resources and act as the link
person to follow on patient’s care plan. The patient and
family were invited to complete the Medical Outcomes
StudyeShort Form Health Survey Questionnaire (SF-36),14
Social Support Survey (SSS),15 and Caregiver Strain Index
(CSI).16 SF-36 was not performed for all hospitalized patients
to avoid undue clinician effect on patient response. With
participation and support by familymembers, thepatientwas
empowered to make an informed choice of future medical
care, including RPC if the patients decided to forgo dialysis.8
Reasons for patients forgoing dialysis were classified into
physical, psychological, and social burdens by the consensus
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social workers in the weekly multidisciplinary case confer-
ence. The ACP was emphasized as an ongoing process with
open-door policy so that the patient could change decision
with time. TheACPprocess and outcomeweredocumented in
a standard form and reviewed in the multidisciplinary case
conference with participation of nephrologists, palliative
care physicians, MSW, as well as renal and palliative care
nurses. Patients who opted for RRT would be followed up at
the predialysis clinic while those who chose RPC would be
followed up in the one-stop multidisciplinary RPC clinic,
supported by the community-based palliative home care
team and admitted to designated beds under the RPC team
for acute medical or end-of-life (EOL) care.8 Bereavement
support was provided to family members and they were
invited to report their satisfaction with the patient care
at EOL.
All patients were followed up to the end of 2011 or
death, whichever was earlier. Continuous data are pre-
sented as mean  standard deviation or median with
interquartile range (IQR). Group comparisons were done by
Fisher’s exact or Pearson’s Chi-square test and Student t
test or ManneWhitney U test when appropriate.
KaplaneMeier survivals were calculated and groups
compared by log-rank test. Multivariate analysis for pre-
dictors of survival was performed by stepwise backward Cox
proportional hazards model. All p values were two-sided
with p < 0.05 indicating statistically significance. SPSS
20.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical
calculations. The study complied with the Declaration of
Helsinki and was approved by clinical research ethics
committee [Trial ID: KW/EX-14-158(78-17)].Results
A total of 600 patients (599 Chinese; 265 RRT and 335 RPC)
were followed up for a median of 782 days (IQR
662e902 days). The median time elapsed after ACP before
reaching a decision was 11.5 days (IQR 0e42 days). Patients
with decisions made before 11.5 days (early decision group)
were more likely to have their ACP conducted in a hospi-
talized setting (45.7% vs. 22%; p < 0.001) with lower esti-
mated glomerular filtration rate (in mL/min/1.73m2,
10.92  5.33 vs. 12.54  4.29; p< 0.001) but were similar
to patients with decisions made after 11.5 days in terms of
age, mCCI and treatment chosen. The early decision group
was more dependent (walks unaided, 59% vs. 70%;
pZ 0.001) and had higher prevalence of congestive heart
failure (29% vs. 18%, pZ 0.002), dementia (9.7% vs. 4%,
pZ 0.009), tumor (11% vs. 5.3%, pZ 0.016), receiving so-
cial security support (39.7% vs. 23.3%, p< 0.001) and being
institutionalized (14.7% vs. 7.7%, pZ 0.025).
Compared with male patients, female patients were
older and functionally less mobile. They had lower eGFR
and hemoglobin, higher calcium-phosphate product, but
similar mCCI (Table 1). More women were illiterate but
their mental competence to make an informed decision did
not differ. For women, children were more often involved
than spouses in ACP discussion. Moreover, women relied
more on family members for decision making and more
opted for RPC (Tables 2 and 3). Although women scoredlower in the general health, physical functioning, bodily
pain, and mental health domains of SF-36, they perceived
better social support in their emotional, affectionate, and
positive social interaction aspects than men (Table 4).
Patients who chose RRT and RPC differed in their de-
mographics, social characteristics and functional status
(Table 1). RPC patients were older and more were illiterate
and being institutionalized. They had higher mCCI and more
comorbidities including DM, congestive heart failure, and
ischemic heart disease. Financially, fewer RPC patients
lived on their own income or savings but more often relied
on social security support. Fewer RPC patients had full
mental capacity or could walk independently. The majority
(87.2%) of patients and relatives declined dialysis because
of perceived physical burden (Tables 1e3). SF-36 and SSS
were completed for 268 and 267 patients, respectively.
There were 202 main caregivers who completed the CSI.
RPC patients scored lower in the general health and phys-
ical functioning domains of SF-36 but maintained compa-
rable, if not better, QOL in other areas when compared
with RRT patients or the general Hong Kong population. The
two groups did not differ in perceived social support and
main carer’s stress (Table 4).
Crude mortalities were 24.2% and 67.5% in RRT and RPC
groups, respectively. Among the 335 RPC patients, five
(1.6%) changed their decision and commenced on dialysis
(1.6%) but 3 of them died before study end date. One- and
3-year survival (in %, RRT vs. RPC) was 89.7  2.1 versus
57.3  2.9 and 74.6  3.4 versus 16  2.7, respectively.
Survival plots, categorized according to mCCI quartiles,
were shown in Figure 1. Survival of the lowest quartile
patients nearly doubled that of the second quartile. Results
of univariate and multivariate analyses of risk factors on
mortality are shown in Table 5. Older age, mental incom-
petence, hyperlipidemia, high mCCI, low eGFR, and low
albumin remained as important independent predictors of
poor survival.
Symptom prevalence, medical interventions and health
care services of RPC patients were reported elsewhere.20 A
total of 112 bereaved family members of RPC patients were
interviewed. For satisfaction with EOL care and death
scene, 92.9% were fully satisfied, 5.4% partially satisfied
and 1.8% not satisfied. As for the decision made after ACP,
98.1% were fully satisfied with the choice of palliative care
and none had regret. Symptom control was perceived as
most helpful in 90.7%, psychosocial support in 79.4%, and
tangible support in 76.6%. No patient signed advance
directive in our study cohort.Discussion
The Hospital Authority provides public health care services
to the vast majority of patients in Hong Kong and is facing
the challenge of aging population. The peritoneal dialysis
(PD) first policy contributed to equitable access to dialysis.
Despite increasing utilization of hemodialysis, PD still
accounted for three-quarters of the dialysis population in
2011.21
Much has been discussed in the literature on ACP model
with respect to withdrawing and withholding dialysis. The
five key components and its integration into a nephrology
Table 1 Patients’ medical conditions.
All (nZ 600) Male (nZ 342) Female (nZ 258) p RRT (nZ 265) RPC (nZ 335) p
Age (y) 68.7  14.1 67.1  13.6 70.8  14.5 0.001 58.6  12.6 76.8  9.1 < 0.001
Cause of CRF 0.185 < 0.001
Diabetes mellitus 349 (58.2%) 202 (59.1%) 147 (57%) 137 (51.7%) 212 (63.3%)
Hypertension 61 (10.2%) 29 (8.5%) 22 (12.4%) 14 (5.3%) 47 (14.0%)
Glomerulonephritis 49 (8.2%) 25 (7.3%) 24 (9.3%) 44 (16.6%) 5 (1.5%)
Polycystic kidney
disease
5 (0.8%) 5 (1.5%) 0 (0.0%) 4 (1.5%) 1 (0.3%)
Unknown 108 (18.0%) 63 (18.4%) 45 (17.4%) 53 (20%) 55 (16.4%)
Others 28 (4.7%) 18 (5.3%) 10 (3.9%) 13 (4.9%) 15 (4.5%)
Mobility 0.029 < 0.001
Walks unaided 387 (64.5%) 235 (68.7%) 152 (58.9%) 231 (87.2%) 156 (46.6%)
Walks with aid 152 (25.3%) 76 (22.2%) 76 (29.5%) 27 (10.2%) 125 (37.3%)
Chair-bound 55 (9.2%) 26 (7.6%) 29 (11.2%) 7 (2.6%) 48 (14.3%)
Bed-bound 6 (1%) 5 (1.5%) 1 (0.4%) 0 (0%) 6 (1.8%)
Charlson Comorbidity
Indexa
7.70  2.77 7.69  2.75 7.71  2.80 0.919 6.20  2.61 8.88  2.28 < 0.001
Other co-morbid conditions
Hypertension 533 (88.8%) 297 (86.8%) 236 (91.5%) 0.089 234 (88.3%) 299 (89.3%) 0.794
Diabetes mellitus 372 (62.0%) 219 (64.0%) 153 (59.3%) 0.269 150 (56.6%) 222 (66.3%) 0.018
Hyperlipidemia 168 (28%) 87 (25.4%) 81 (31.4%) 0.119 122 (46.0%) 46 (13.7%) < 0.001
Ischemic heart
disease
148 (24.7%) 85 (24.9%) 63 (24.4%) 0.924 47 (17.7%) 101 (30.1%) 0.001
Congestive heart
failure
141 (23.5%) 83 (24.3%) 58 (22.5%) 0.628 40 (15.1%) 101 (30.1%) < 0.001
Stroke 130 (21.7%) 80 (23.4%) 50 (19.4%) 0.271 34 (12.8%) 96 (28.7%) < 0.001
COPD 18 (3.0%) 14 (4.1%) 4 (1.6%) 0.091 1 (0.4%) 17 (5.1%) < 0.001
Dementia 41 (6.8%) 20 (5.8%) 21 (8.1%) 0.327 1 (0.4%) 40 (11.9%) < 0.001
Laboratory results
Hemoglobin (g/dL) 9.06  1.78 9.34  1.86 8.69  1.60 < 0.001 9.18  1.82 8.96  1.74 0.140
eGFR
(mL/min/1.73m2)b
11.73  4.90 12.75  5.28 10.38  3.96 < 0.001 10.69  4.86 12.55  4.78 < 0.001
Calcium (mM) 2.07  0.24 2.06  0.23 2.09  0.24 0.117 2.03  0.25 2.10  0.22 0.001
Phosphorus (mM) 1.66  0.50 1.65  0.57 1.68  0.40 0.478 1.78  0.57 1.57  0.41 < 0.001
CaPO4 (mM
2) 3.40  0.95 3.35  1.05 3.48  0.78 0.100 3.57  1.06 3.26  0.82 < 0.001
Albumin (g/L) 30.00  6.14 29.94  6.34 30.08  5.88 0.791 29.51  6.06 30.38  6.19 0.091
RPC depicted patients who chose palliative care and had been enrolled into the comprehensive RPC program; RRT depicted patients who
chose RRT but might or might not have been started on dialysis at the end of study.
CaPO4Z calcium phosphate product; COPDZ chronic obstructive pulmonary disease; CRFZ chronic renal failure; eGFRZ estimated
glomerular filtration rate; RPC Z renal palliative care; RRT Z renal replacement therapy.
a Modified version as described by Beddhu et al.13
b Calculated by the abbreviated Chinese modification of the Modification of Diet in Renal Disease (MDRD) formula.17
22 S.-K. Yuen et al.program was described as: (1) facilitated ACP; (2) docu-
mentation; (3) timing; (4) systems and processes; and (5)
quality improvement.11 However, systematic integration of
ACP and palliative care into the renal program has yet to be
seen on a wider scale. In a US study of dialysis patients, <
10% reported had had discussion about end-of-life care is-
sues with their nephrologist in the past 12 months.22
One needs to answer several important questions when
reviewing any ACP process. Did patients engage in lucid
discussion? Did we offer care options appropriate to the
patient’s treatment goal and preference? Did we empower
the patients to make their own choice? Lastly, did their
choices translate into satisfaction with EOL experiences?
In our cohort, 92.8% of patients were involved in lucid
ACP discussion. Adopting a specific serum creatinine levelas a trigger for ACP ensure timely referral to nephrologist
for expert review and allowed sufficient time for ACP dis-
cussion. Engagement with patients is essential before
cognitive decline that might be related to uremia, de-
mentia, or cerebrovascular complications. Hasty or late
decision for initiation of dialysis is a known predictor of
poor outcome for elders.23
Discussion on prognosis was a core part of ACP. Our pa-
tients who chose RPC had poor prognostic indicators for
dialysis outcome and survival as reported in the literature,
namely age above 75 years, DM, ischemic heart disease,
and high mCCI.24e26 Patients aged over 80 years and elders
in residential homes who commenced RRT experienced
significant and sustained loss of functional capacity soon
after treatment.27 Although age should not be the critical
Table 2 Patients’ socioeconomic status.
All (nZ 600) Male (nZ 342) Female (nZ 258) p RRT (nZ 265) RPC (nZ 335) p
Recipient of CSSA 189 (31.5) 113 (33) 76 (29.5) 0.249 77 (29.1) 112 (33.4) 0.005
Household members 0.244 < 0.001
Alone 86 (14.3) 53 (15.5) 33 (12.8) 35 (13.2) 51 (15.2)
Relatives 445 (74.2) 257 (75.1) 188 (72.9) 221 (83.4) 224 (66.9)
Unrelated 12 (2.0) 5 (1.5) 7 (2.7) 1 (0.4) 11 (3.3)
Type of abode 0.099 < 0.001
Public housing 303 (50.5) 172 (50.3) 131 (50.8) 114 (43) 189 (56.4)
Private rental 59 (9.8) 41 (12) 18 (7) 38 (14.3) 21 (6.3)
Self-owned premise 125 (20.8) 66 (19.3) 59 (22.9) 64 (24.2) 61 (18.2)
Institution 67 (11.2) 32 (9.4) 35 (13.6) 15 (5.7) 52 (15.5)
Others 8 (1.3) 6 (1.8) 2 (0.8) 4 (1.5) 4 (1.2)
Education level < 0.001 < 0.001
Illiterate 165 (27.5) 49 (14.3) 116 (45) 19 (7.2) 146 (43.6)
Primary School 247 (41.2) 167 (48.8) 80 (31) 113 (42.6) 134 (40.0)
Secondary 98 (16.3) 66 (19.3) 32 (12.4) 78 (29.4) 20 (6.0)
Above secondary 11 (1.8) 9 (2.6) 2 (0.8) 9 (3.4) 2 (0.6)
Tertiary or above 12 (2.0) 11 (3.2) 1 (0.4) 10 (3.8) 2 (0.6)
Others 1 (0.2) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.3)
Religion 0.602 0.415
Buddhism 17 (2.8) 9 (2.6) 8 (3.1) 4 (1.5) 13 (3.9)
Taoism 4 (0.7) 2 (0.6) 2 (0.8) 3 (1.1) 1 (0.3)
Catholic 7 (1.2) 4 (1.2) 3 (1.2) 3 (1.1) 4 (1.2)
Christian 13 (2.2) 6 (1.8) 7 (2.7) 6 (2.3) 7 (2.1)
Others 2 (0.3) 0 (0) 2 (0.8) 1 (0.4) 1 (0.3)
Nil 489 (81.5) 278 (81.3) 211 (81.8) 213 (80.4) 276 (82.4)
Data are presented as n (%).
CSSAZ Comprehensive Social Security Allowance; RPC Z renal palliative care; RRT Z renal replacement therapy.
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attention to diabetic elders when discussing treatment
options for ESRD, as specific clinical and psychosocial situ-
ations might mean they had prioritization for their personal
decision process as compared with young people.28
Prognostic telling could be difficult especially for non-
cancer. We adopted mCCI for assessment of baseline
comorbidities and confirmed survival to be extremely poor
with mCCI> 10. Every single point increase in mCCI trans-
lated into 11% increase in mortality after ACP. In the
literature, an index based on mortality analyses of the
United States Renal Data System incorporating 11 weighted
comorbid conditions might outperform mCCI in terms of
predictability.29 Another index with nine variables devel-
oped for predicting dialysis outcome for the elders included
factors that were not covered by mCCI, namely, body mass
index <18.5 kg/m2, dysrhythmia, severe behavioral disor-
der, total dependency for transfers, and unplanned dial-
ysis.23 These indices help identify patients for whom
palliative care might be more appropriate by prognostic
telling. However, for individual patients, they fall short of
predicting their lives without dialysis. Instead of steering
medical decision, indices serve more to assist in deciding
personalized care.30
As for the socioeconomic status, patients in our RPC
group appeared disadvantaged in terms of financial sup-
port, education, and institutionalization. They belonged to
the older generation who did not benefit from the
contemporary free compulsory education. With the familyas a unit during ACP, low patient education was not a bar-
rier in comprehension in our experience. The social security
system also protected the deprived and ensured equitable
access to dialysis. Despite the lower socioeconomic status,
patients who declined dialysis perceived similar social
support as those who chose dialysis. While we acknowledge
the great difference in the proportion of nonhospitalized
patients who had completed the SF-36 questionnaire (189/
217 or 87.1% and 79/177 or 44.6% in the RPC and RRT
groups, respectively), we postulate that the comparable
scores in SF-36 mental health domain, SSS, and CSI among
RPC patients to the general or RRT populations might sug-
gest they did not decline dialysis because of issues related
to mental distress, social support, or caregiver stress.
Alternatively, one may postulate that good psychosocial
support, often considered an important factor to sustain a
patient through dialysis, might also be an important
empowerment factor for patients to decline dialysis.
Sex differences were apparent with women possessing
poorer risk profile as exemplified by their age, activity of
daily-living, eGFR, hemoglobin, and calcium-phosphate
product. The age difference might merely reflect the
longer life expectancy in women, which was 86.7 years in
2011, as compared with 80.3 years for men.31 For female
patients, their children instead of spouses were often
involved in ACP. Despite unfavorable medical and socio-
economic status, women perceived better social support
without imposing higher strain to their main caregiver. The
Chinese tradition of filial piety came into play when
Table 3 The advance care planning process.
All
(nZ 600)
Male
(nZ 342)
Female
(nZ 258)
p RRT
(nZ 265)
RPC
(nZ 335)
p
Place of first ACP interview 0.728 0.665
Hospital (in-patient) 206 (34.3) 115 (33.6) 91 (35.3) 88 (33.2) 118 (35.2)
Clinic (out-patient) 394 (65.7) 227 (66.4) 167 (64.7) 177 (66.8) 217 (64.8)
Facilitated by 0.011 < 0.001
Nephrologist 484 (80.7) 283 (82.7) 201 (77.9) 243 (91.7) 241 (71.9)
Other internist 76 (12.7) 32 (9.4) 44 (17.1) 3 (1.1) 73 (21.8)
Mental competence 0.206 < 0.001
Full 522 (87) 304 (88.9) 218 (84.5) 259 (97.7) 263 (78.5)
Limited 52 (8.7) 27 (7.9) 25 (9.7) 6 (2.3) 46 (13.7)
Incompetent 26 (4.3) 11 (3.2) 15 (5.8) 0 (0) 26 (7.8)
Discussant
Patient 557 (92.8) 323 (94.4) 234 (90.7) 0.081 265 (100) 292 (87.2) < 0.001
Any family member 451 (75.2) 245 (71.6) 206 (79.8) 0.022 171 (64.5) 280 (83.6) < 0.001
Spouse 184 (30.7) 138 (40.4) 46 (17.8) < 0.001 97 (36.6) 87 (26) 0.006
Children 319 (53.2) 154 (45) 165 (64) < 0.001 99 (37.4) 220 (65.7) < 0.001
Parents 8 (1.3) 7 (2) 1 (0.4) 0.147 8 (3) 0 (0) 0.001
Others 77 (12.8) 38 (11.1) 39 (15.1) 0.175 26 (9.8) 51 (15.2) 0.050
Friends 5 (0.8) 3 (0.9) 2 (0.8) 1.000 2 (0.8) 3 (0.9) 1.000
Median (IQR) days lapsed
till decision made
11.5 (0e42) 9 (0e38) 14.5 (0e49.25) 0.009 14 (0e46.5) 10 (0e38) 0.088
Opted for 0.009 < 0.001
RPC 335 (55.8) 173 (50.6) 162 (62.8) 0 (0) 335 (100)
Peritoneal dialysis 238 (39.7) 155 (45.3) 83 (32.2) 238 (89.8) 0 (0)
Hemodialysisa 26 (4.3) 13 (3.8) 13 (5) 26 (9.8) 0 (0)
Pre-emptive transplant 1 (0.2) 1 (0.3) 0 (0) 1 (0.4) 0 (0)
Decision made by 0.019 < 0.001
Patient 248 (41.3) 153 (44.7) 95 (36.8) 120 (45.3) 128 (38.2)
Patient and family 304 (50.7) 169 (49.4) 135 (32.3) 143 (54) 161 (48.1)
Family 46 (7.7) 18 (5.3) 28 (10.9) 2 (0.8) 44 (13.1)
Doctor 2 (0.3) 2 (0.5) 0 (0) 0 (0) 2 (0.6)
Main reason for forgo RRT (nZ 335) (nZ 173) (nZ 162)
Physical burden 292 (87.2) 153 (88.4) 139 (85.8) 0.593
Psychological burden 28 (8.4) 9 (5.2) 19 (11.7) 0.088
Social burden 73 (21.8) 44 (25.4) 29 (17.9) 0.207
More than One burden 57 (17.2) 34 (19.9) 23 (14.3) 0.192
(nZ 332) (nZ 171) (nZ 161)
Change of decisionb 0.051 < 0.001
Yes 7 (1.2) 4 (1.2) 3 (1.2) 2 (0.8) 5 (1.5)
No 317 (52.8) 166 (48.5) 151 (58.5) 70 (26.4) 247 (73.7)
Outcome undetermined 276 (46) 172 (50.3) 104 (40.3) 193 (72.8) 83 (24.8)
Data are presented as n (%).
IQR Z interquartile range; RPC Z renal palliative care; RRT Z renal replacement therapy.
a Hong Kong public renal services maintained the ‘peritoneal dialysis first’ policy but hemodialysis at private hospitals remained an
option for discussion in advance care planning.
b For RPC patients, this was defined whenever the patient underwent any form of RRT by the end of study. For RRT patients, this was
defined only if the patient died with a final decision of declining RRT. Outcomes were considered still undetermined for surviving RPC
patients or RRT patients who had not yet started on RRT.
24 S.-K. Yuen et al.patients’ children were involved. Although new generations
in Hong Kong adhere less to filial commitments in terms of
total submission or sacrificing self-interest for parents (i.e.
at all costs), reciprocal filial piety as guided by spontaneous
affection is now more prominent.32 ACP facilitators have to
be culturally sensitive.
Family involvement was not only important on its own
but could also serve as a source of emotional support.22 TheACP offered the opportunity for the patient to share their
values and preferences for the better understanding by
family members and professionals, without which, pre-
sumptions can deviate considerably from the patient’s
wishes.33 Although one of the objectives of ACP was to
enhance patient’s autonomy, Chinese were more likely to
adopt family-based decision making instead of individual-
istic approach.34 Published Hong Kong guidelines on
Table 4 Quality of life as assessed by SF-36.
Domain General
populationa
Our study cohortb
All (nZ 268) Male (nZ 159) Female (nZ 109) p RRT (nZ 79) RPC (189) p
GH 55.98  20.18 51.37  19.32 55.07  15.30 45.96  11.41 < 0.001 53.93  10.46 50.30  15.97 < 0.001
PF 91.83  12.89 83.40  24.62 87.18  19.24 77.89  14.87 < 0.001 88.67  13.41 81.20  20.29 < 0.001
RP 82.43  30.97 77.31  23.71 82.03  18.68 70.43  14.14 0.925 81.76  12.88 75.46  19.56 0.767
RE 71.66  38.36 77.84  23.82 79.06  18.35 76.06  14.76 0.291 77.73  12.58 77.89  19.91 0.374
SF 91.19  16.57 92.40  25.93 93.05  19.89 91.45  16.17 0.286 92.88  13.73 92.20  21.65 0.488
BP 83.98  21.89 80.27  24.16 85.37  19.06 72.84  14.38 0.003 83.47  13.02 78.93  20.02 0.115
VT 60.27  18.65 60.69  21.02 63.05  16.38 57.26  12.78 0.384 61.52  11.18 60.35  17.52 0.940
MH 72.79  16.57 75.31  23.42 76.67  18.07 73.31  14.48 0.010 74.48  12.30 75.65  19.62 0.008
(nZ 267) (nZ 158) (nZ 109) (nZ 78) (nZ 189)
ES 54.30  21.50 49.4  21.65 61.4  19.27 < 0.001 52.09  21.17 55.21  21.63 0.282
TS 70.40  31.88 68.99  32.33 72.44  31.24 0.386 64.93  31.06 72.65  32.02 0.072
AS 60.78  27.01 56.19  27.78 67.43  24.47 0.001 58.87  25.75 61.57  27.54 0.459
PSI 54.03  26.08 51.27  27.00 58.04  24.24 0.037 51.46  23.04 55.10  27.21 0.268
(nZ 202) (nZ 118) (nZ 84) (nZ 60) (nZ 142)
CSI 1.62  2.65 1.78  2.67 1.40  2.62 0.323 1.52  2.63 1.67  2.67 0.710
SF-36 domains included: BPZ bodily pain; GHZ general health; MHZ mental health; PFZ physical functioning; REZ role limitation
by emotional; RP Z Role limitation by Physical; SFZ Social Functioning; VT Z vitality.
SSS domains included: AS Z affectionate support; ES Z emotional support; PSI Z positive social interaction; TS Z tangible support.
CSIZ Caregiver’s Stress Index; SF-36 Z Medical Outcomes Study (MOS)-Short Form Health Survey Questionnaire; SSSZ Social Support
Survey.
a Data according to Lam et al.18
b Data expressed as means  standard deviations. Means and standard deviations were adjusted as described by Yong et al.19
Advance care planning for ESRD 25withholding or withdrawing life-sustaining treatment in the
terminally ill also recommend a consensus-building
approach with the patients and families.35 However, a
sizeable proportion (38.2%) of our patients actually
preferred to make decisions on their own. Health care
professionals should be aware that many local elders, evenFigure 1 KaplaneMeier survival plots of patients since advance c
(mCCI). 1 Z first quartile (mCCI < 6); 2 Z second quartile (mCC
(mCCI  11).with little education, would like to exert their autonomy
when they are empowered to do so.
ACP is a facilitator-dependent process with potential
pitfalls that need safeguards. One of the concerns is pres-
ence of undue clinician influence on patients to forgo or to
accept interventions.36 In a Canadian study, 61% of ESRDare planning according to modified Charlson Comorbidity Index
I 6e7); 3 Z third quartile (mCCI 8e10); 4 Z fourth quartile
Table 5 Impact of selected variables at advance care planning on mortality.
Variable Univariate analysis Multivariate analysisa
HR 95% CI p Adjusted HR 95% CI p
Each y older 1.052 1.042e1.063 < 0.001 1.033 1.020e1.047 < 0.001
Hyperlipidemia 0.413 0.306e0.557 < 0.001 1.661 1.189e2.321 0.003
Each 1-point increase in mCCI 1.228 1.182e1.276 < 0.001 1.111 1.055e1.171 < 0.001
Each day elapsed from ACP until decision made 0.999 0.999e1.000 0.018 0.999 0.999e1.000 0.032
Each 1-g/dL rise in hemoglobin 0.858 0.803e0.917 < 0.001 NS
Each 1-mL/min/1.73m2 rise in eGFR 0.981 0.958e1.005 0.113 0.962 0.937e0.987 0.003
Each 1-g/L rise in albumin 0.958 0.941e0.975 < 0.001 0.967 0.946e0.968 < 0.001
Each 1mM rise in calcium 0.632 0.409e0.977 0.039 NS
Mentally competent 0.546 0.473e0.631 < 0.001 0.605 0.423e0.864 0.006
Being present at the time of ACP 0.417 0.349e0.498 < 0.001 NS
Being an in-hospital patient at the time of ACP 1.402 1.249e1.575 < 0.001 NS
ACP facilitated by nephrologist 0.691 0.599e0.797 < 0.001 NS
Being institutionalized 2.04 1.49e2.809 < 0.001 NS
Being illiterate 1.408 1.193e1.661 < 0.001 NS
Being male 0.817 0.649e1.030 0.088
Diabetes mellitusb 1.193 1.055e1.350 0.005
On Comprehensive Social Security Allowance 1.07 0.834e1.371 0.596
No religious belief 0.929 0.737e1.171 0.534
Each 1mM rise in phosphate 1.182 0.968e1.444 0.102
Each 1mM2 rise in CaPO4 product 1.080 0.962e1.212 0.194
ACP Z advance care planning; CI Z confidence interval; eGFR Z estimated glomerular filtration rate; HR Z hazards ratio;
mCCI Z modified Charlson Comorbidity Index; NS Z not significant (p > 0.05).
a Multivariate analysis by Cox proportional hazards model. Variables showing statistical non-significance were denoted as NS.
b Diabetes mellitus was not entered into multivariate analysis since it is well-represented in the modified Charlson Comorbidity Index.
26 S.-K. Yuen et al.patients regretted their decision to start dialysis. Surpris-
ingly enough, the majority did so because of doctors’
(51.9%) and families’ (13.9%) wishes, while only 34.2% of
them regarded the decision to be a personal preference.22
Health care workers should be aware of patients’ perplexity
in withholding potentially life-saving treatment but to
remain empathetic and open-minded since ACP should not
involve only a single discussion but most often a continuous
process. Our open-door policy enabled patients to re-
consider their care option and was pivotal to its success.
Completion of advance directive form was uncommon in
Hong Kong at the time of our study. However, the territory-
wide electronic clinical management system served as a
platform for clinicians to document the ACP discussion and
decisions that could facilitate continuity of care.
In our study cohort, patients rarely changed their mind
after an ACP decision had been made. As shown in Table 3,
however, a sizeable proportion of them were classified as
having undermined outcome at the end of the study.
Undermined outcome was defined for any RPC patient who
was still surviving (since there would be a chance that they
choose RRT before death) or for any RRT patient who had
not yet been started on RRT (since there would be a chance
that they forgo dialysis and die subsequently of ESRD).
While one might view these data skeptically, it was our
experience that the rate of decision change been consis-
tently lower than 5% over recent years.
The success of ACP could be difficult to measure. Instead
of targeting the completion rate of advance directive, we
may have to refocus on the discussion process and the ul-
timate goal of improving EOL care. Surrogate markersincluded increased referral to palliative care service,
increased likelihood of patients’ wishes being respected
and reduced family distress.37,38 In Hong Kong, where
advance directive is not legislated and uncommonly done,
satisfaction with EOL care should be a more direct assess-
ment tool of the ACP process in future studies.
Conclusion
With a structured renal ACP process for ESRD patients, the
vast majority of our patients engaged in lucid communica-
tion with family members’ participation. The majority of
patients forgo dialysis because of perceived physical
burden. Change of treatment decision occurred
uncommonly.
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